Product Description
Tripoclav-500 Capsules is a broad-spectrum antibiotic formulation containing Amoxicillin and Potassium Clavulanate, designed to effectively treat a wide range of bacterial infections. This combination enhances antibacterial activity by inhibiting beta-lactamase enzymes, thereby improving the efficacy of Amoxicillin against resistant strains.
Tripoclav-500 is widely prescribed for the treatment of respiratory tract infections, ENT infections, urinary tract infections, skin and soft tissue infections, and other bacterial conditions. The formulation ensures reliable therapeutic action with improved patient compliance.
Manufactured under stringent quality standards, Tripoclav-500 Capsules are suitable for distribution, institutional supply, and bulk procurement. The product is available in secure blister packaging ensuring stability and quality.